- recruitingPHASE4
The STOP-MED CTRCD Trial
This study looks at whether it's safe for cancer survivors to stop heart failure medicines if their heart has recovered well. It's for people whose hearts were affected by cancer treatment but are now working normally again.
United States · Australia · Canada - active not recruiting
BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
This study looks at how new cancer drugs, called immunotherapies and anti-angiogenesis medicines, affect your blood vessels and heart. We want to understand why some patients get heart problems or strokes when taking these important cancer treatments.
United Kingdom